Global Pre-filled Syringes Market 2017-2021 - Product Image

Global Pre-filled Syringes Market 2017-2021

  • ID: 4328360
  • Report
  • Region: Global
  • 94 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AptarGroup
  • Baxter
  • BD
  • Bespak
  • Gerresheimer
  • NIPRO
  • MORE
About Pre-filled Syringes

The pre-filled syringe was introduced in the market in around 1975 as a part of the injectable drug delivery devices. It gained popularity and became the preferred packaging and delivery device for injectable drugs after the successful introduction of heparin pre-filled syringe by Sanofi and Rhone-Poulenc Rorer into the European market in the early 1980s. Approximately three to four billion pre-filled syringes are being produced annually and are expected to increase by 8%-10% every year. There is a deep interest in the healthcare industry for pre-filled syringe because of its convenience and acceptance by patients, indicating the strong growth potential of the pre-filled syringes market.

The analysts forecast the global pre-filled syringes market to grow at a CAGR of 10.07 % during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global pre-filled syringes market for 2017-2021. To calculate the market size, the report considers the sales/value of pre-filled syringes.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Pre-filled Syringes Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • BD
  • Gerresheimer
  • SCHOTT
  • Baxter
  • TERUMO
Other prominent vendors
  • AptarGroup
  • Bespak
  • Medtronic Minimally Invasive Therapies (formerly known as Covidien)
  • NIPRO
  • SHL Group
  • STERINOVA
  • UNILIFE
  • Vetter Pharma-Fertigung GmbH & Co.
  • West Pharmaceutical Services
Market drivers
  • Favorable regulations and guidelines
  • For a full, detailed list, view the full report
Market challenges
  • Competition from alternative drug delivery systems
  • For a full, detailed list, view the full report
Market trends
  • Shift from glass pre-filled syringes to plastic pre-filled syringes
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AptarGroup
  • Baxter
  • BD
  • Bespak
  • Gerresheimer
  • NIPRO
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by material type
  • Market overview
  • Market size and forecast
  • Glass pre-filled syringes
  • Plastic pre-filled syringes
PART 07: Market segmentation by application
  • Market overview
  • Market size and forecast
  • Insulin pre-filled syringes
  • Vaccine pre-filled syringes
  • Anticoagulants pre-filled syringes
  • Others
PART 08: Market segmentation by end-user
  • Market size and forecast
  • Hospitals and clinics
  • Home healthcare
PART 09: Geographical segmentation
  • Market size and forecast
  • EMEA
  • Americas
  • APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Market challenges
PART 12: Market trends
  • Shift from glass pre-filled syringes to plastic pre-filled syringes
  • Change in strategy for introduction of drug pre-filled syringes into the market
  • Innovations in pre-filled syringes
  • Increasing demand for auto-injector/pre-filled syringes combination devices
PART 13: Vendor landscape
  • Competitive landscape
PART 14: Key vendor analysis
  • Baxter
  • BD
  • Gerresheimer
  • SCHOTT
  • TERUMO
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global pre-filled syringes market segmentation
Exhibit 02: Global pre-filled syringes market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Pre-filled syringes available in the market
Exhibit 05: Global pre-filled syringes market share by material type 2016 (%)
Exhibit 06: Global glass pre-filled syringes market 2016-2021 ($ millions)
Exhibit 07: Global plastic pre-filled syringes market 2016-2021 ($ millions)
Exhibit 08: Pre-filled syringes market opportunities in key applications
Exhibit 09: Global pre-filled syringes market share by application 2016 (%)
Exhibit 10: Global insulin pre-filled syringes market: Overview
Exhibit 11: Global vaccine pre-filled syringes market: Overview
Exhibit 12: Global anticoagulants pre-filled syringes market: Overview
Exhibit 13: Drugs in pre-filled syringes marketed for other diseases
Exhibit 14: Drugs in pre-filled syringes in clinical trials for other diseases
Exhibit 15: Global pre-filled syringes market by end-users 2016 (%)
Exhibit 16: Factors influencing the adaptation of pre-filled syringes in hospitals and clinics
Exhibit 17: Factors influencing the adaptation of pre-filled syringes in home healthcare
Exhibit 18: Global pre-filled syringes market by geography 2016 (%)
Exhibit 19: Pre-filled syringes market in EMEA 2016-2021: Overview
Exhibit 20: Pre-filled syringes market in EMEA 2016-2021 ($ millions)
Exhibit 21: Pre-filled syringes market in Americas 2016-2021: Overview
Exhibit 22: Pre-filled syringes market in Americas 2016-2021 ($ millions)
Exhibit 23: Pre-filled syringes market in APAC 2016-2021: Overview
Exhibit 24: Pre-filled syringes market in APAC 2016-2021 ($ millions)
Exhibit 25: Baxter: Key highlights
Exhibit 26: Baxter: Strength assessment
Exhibit 27: Baxter: Strategy assessment
Exhibit 28: Baxter: Opportunity assessment
Exhibit 29: BD: Key highlights
Exhibit 30: BD: Strength assessment
Exhibit 31: BD: Strategy assessment
Exhibit 32: BD: Opportunity assessment
Exhibit 33: Gerresheimer: Key highlights
Exhibit 34: Gerresheimer: Strength assessment
Exhibit 35: Gerresheimer: Strategy assessment
Exhibit 36: Gerresheimer: Opportunity assessment
Exhibit 37: SCHOTT: Key highlights
Exhibit 38: SCHOTT: Strength assessment
Exhibit 39: SCHOTT: Strategy assessment
Exhibit 40: SCHOTT: Opportunity assessment
Exhibit 41: TERUMO: Key highlights
Exhibit 42: TERUMO: Strength assessment
Exhibit 43: TERUMO: Strategy assessment
Exhibit 44: TERUMO: Opportunity assessment
Exhibit 45: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AptarGroup
  • Baxter
  • BD
  • Bespak
  • Gerresheimer
  • NIPRO
  • MORE
New Report Released: - Global Pre-filled Syringes Market 2017-2021

The author of the report recognizes the following companies as the key players in the global pre-filled syringes market: BD, Gerresheimer, SCHOTT, Baxter, and TERUMO.

Other Prominent Vendors in the market are: AptarGroup, Bespak, Medtronic Minimally Invasive Therapies (formerly known as Covidien), NIPRO, SHL Group, STERINOVA, UNILIFE, Vetter Pharma-Fertigung GmbH & Co., and West Pharmaceutical Services.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Shift from glass pre-filled syringes to plastic pre-filled syringes .The plastic pre-filled syringes are becoming more popular due to the introduction of advanced polymer materials such as polypropylene and crystal-clear polymer, which are biocompatible with the other components of the syringe. Currently, the majority of pre-filled syringes in the global market were made of glass. However, over time manufacturers are switching to plastic as their preferred material for pre-filled syringe due to the inherent drawbacks of glass pre-filled syringes such as susceptibility to breakage and interaction with drugs.”

According to the report, one of the major drivers for this market is Favorable regulations and guidelines. In developed countries such as the US and Canada, there are laws or guidelines for mandatory protection of healthcare workers from needlestick injuries. In this context, the pre-filled syringes become an attractive choice, as it is equipped with needle safety devices, which can help to prevent the needle stick injuries. Many pre-filled syringes in the market provide features like automatic needle shielding or retractable needle options for safety from needle stick injuries.

Further, the report states that one of the major factors hindering the growth of this market is Competition from alternative drug delivery systems. The pre-filled syringes market faces intense competition from many alternative drug delivery systems such as microneedles, wearable and connected delivery devices, and nanopatches. These drug delivery devices are non-invasive, which are easier to use, provide painless delivery, and ensure the controlled release of the drug. However, the delivery of medicine by using pre-filled syringes is not pain-free. Hence, these novel technologies are expected to occupy a significant market share of the global drug delivery market. Companies such as UNILIFE and BD have already introduced wearable injector devices in the market. These devices are used as an alternative to hand-held instruments such as pre-filled syringes, particularly when delivering a dosage over pre-programmed periods from minutes to hours. Wearable injectors can be used to give a customizable dosage of biologics, vaccines, and small molecules to the patients.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • BD
  • Gerresheimer
  • SCHOTT
  • Baxter
  • TERUMO
  • AptarGroup
  • Bespak
  • Medtronic Minimally Invasive Therapies (formerly known as Covidien)
  • NIPRO
  • SHL Group
  • STERINOVA
  • UNILIFE
  • Vetter Pharma-Fertigung GmbH & Co.
  • West Pharmaceutical Services
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll